Deputy Chairman and Senior Independent Director
Stuart Henderson was appointed to Oxford Biomedica's Board as a Non-executive Director and Chair of the Audit Committee in June 2016. He became Deputy Chairman and Senior Independent Director in June 2020. Previously, he was a partner at Deloitte, where he was Head of European Healthcare and Life Sciences. Prior to this he was partner at Arthur Andersen, where he was Head of Emerging Biotechnology. He has extensive audit and transaction experience and has worked with life sciences businesses ranging from start-ups to multinationals, as well as acting as reporting accountant on numerous IPO and Class 1 transactions. As Audit Partner, he has reported to the audit committees of publicly quoted companies for over 20 years. He is a former director of the Babraham Institute and currently sits as a non-executive director on the Boards of OneNucleus (the Life Sciences trade body for Cambridge and London), Norwich Research Partners LLP and Cell Therapy Catapult Limited.
– Audit Committee (Chair)
– Remuneration Committee
– Nomination Committee